[Other] Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results

DearThao Post time 2024-6-13 09:42:37 | Show all posts |Read mode
Reward10points

Allogeneic BCMA-targeting CAR T cells in relapsed/refractory multiple myeloma: phase 1 UNIVERSAL trial interim results
Author: Sham Mailankody, Jeffrey V. Matous, Saurabh Chhabra, Michaela Liedtke, Surbhi Sidana, Olalekan O. Oluwole, Shahbaz Malik, Rajneesh Nath, Faiz Anwer, Jose Carlos Cruz, Myo Htut, Erin E. Karski, Wade Lovelace, Myles Dillon, Eric Butz, Wendy Ying, Arun Balakumaran & Shaji K. Kumar
Nature Medicine volume 29, pages422–429 (2023)
https://doi.org/10.1038/s41591-022-02182-7

Best Answer

Reply

Use magic Donate Report

All Reply1 Show all posts
fenavi Post time 2024-6-13 09:42:38 | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
Reply

Use magic Donate Report

Intermediate member
  • post

  • reply

  • points

    310

Latest Reply

Return to the list